Betty Z. Benedict Endowment of $2 Million to SCTC:

SCTC - Scleroderma Clinical Trials Consortium

Our Misson

The SCTC is an international consortium representing the vast majority of researchers and clinicians who have particular interest and expertise in the care of, and research in, scleroderma (systemic sclerosis).  The goal of the SCTC is to conduct, sponsor, or facilitate clinical research projects that lead to advances in the management, treatment, and outcomes of patients with scleroderma.  The SCTC aims to represent the views and interests of its membership regarding the performance of clinical research in scleroderma.  The SCTC seeks to ensure that research in scleroderma adheres to high standards for design, conduct, and reporting of results.  The SCTC is particularly focused on improving and developing outcome measures for clinical trials and observational studies, participating in the design and conduct of clinical trials and observational studies, and helping to improve the efficiency of clinical trials.  The SCTC strongly encourages international collaboration, inclusiveness in research groups, and involvement of trainees and junior faculty in all its activities.


Upcoming Meetings

SCTC Annual General Meeting

November 3rd, 2021 9:00am - 11:00am EST

Invitation to the entire SCTC membership, as well as our Industry Roundtable members, to join us for our annual general meeting being held virtual via Zoom.
Presentations from the executive committee and trustees, working groups, and grant winners, as well as any important news and updates!

Registration is required and will be made available soon, along with the meeting agenda, and any other necessary information.

SCTC Roundtable Meeting

December 3rd, 2021 9:00am - 12:00pm EST

Invitation to the entire SCTC membership, as well as our Industry Roundtable members, to join us for our next Roundtable meeting being held virtually via Zoom.
Agenda to be published soon! 

For registration and any other relevant information, please contact Adara Borys at

Find out about the SCTC Benedict Visiting Fellowship Programme

The deadline for the 2021 Betty Z. Benedict Award has now passed, and we are no longer accepting submissions. 

Stay tuned for a grant awardee anouncement in the fall of 2021!

Congratulations to the SCTC 2021 Working Group Grant Winners!

Get Involved with SCTC

2020 Betty Z. Benedict Grant for Proposals to Advance the Science of Outcome Measures in Systemic Sclerosis

Become a Member of SCTC

Please join us. There are two types of Membership to choose from:

>> Full member

>> Provisional Member

Donate to SCTC

Donate today to help SCTC and its mission to support research to establish standard outcome measures for clinical treatment trials so that results can be compared over time and over different patient groups.

Pay Membership Fees

If you are a newly accepted member of the SCTC, please select Initial Fee at $250.00 USD.
If you are a returning member of the SCTC, please select the option of Annual Fee at $200.00 USD.
If your institution is unable to use PayPal, please contact

Membership Fees

© 2021 Scleroderma Clinical Trials Consortium. Designed By Kangablu Ltd